| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1From the Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida; and the 3National Eye Institute, National Institutes of Health, Bethesda, MD.
PURPOSE. The pathogenesis of choroidal neovascularization (CNV) is postulated to be driven by angiogenesis, a process in which the cellular components of the new vessel complex are derived from cells resident within an adjacent preexisting capillary. Recently, an alternative paradigm, termed postnatal vasculogenesis, has been shown to contribute to some forms of neovascularization. In vasculogenesis, the cellular components of the new vessel complex are derived from circulating vascular progenitors from bone marrow. In the current study, transplantation of green fluorescent protein (GFP)-labeled bone marrow and laser-induced CNV were combined to examine the contribution of vasculogenesis to the formation of CNV.
METHODS. Ten adult C57BL/6 female mice were used as recipients for bone marrow transplantation. Bone marrow was obtained from three C57BL/6 female mice transgenic for the ß-actin promoter GFP. One month after bone marrow transplantation, CNV was induced in recipient mice by making four separate burns in the choroid of each eye with a red diode laser. Four weeks after CNV was induced, eyes of recipient mice were processed for immunohistochemistry to detect GFP and markers for vascular smooth muscle cells (
-smooth muscle actin, desmin, and NG2 chondroitin sulfate proteoglycan), endothelial cells (CD31, BS-1 lectin), or macrophages (F4/80).
RESULTS. GFP-labeled cells represented 17% of the total cell population in the lesion. Many of the GFP-labeled cells were immunoreactive for -smooth muscle actin (39%), desmin, NG2, CD31 (41%), BS-1 lectin, or F4/80. GFP-labeled cells were morphologically indistinguishable from cells normally present in CNV lesions.
CONCLUSIONS. This study is the first to demonstrate that bone marrow-derived progenitor cells are a source of endothelial and smooth musclelike cells in CNV.
This article has been cited by other articles:
|
|
 |
|
  M. H. Criswell, W.-Z. Hu, T. J. Steffens, R. Li, and P. Margaron Comparing Pegaptanib and Triamcinolone Efficacy in the Rat Choroidal Neovascularization Model Arch Ophthalmol, July 1, 2008; 126(7): 946 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Thill, N. V. Strunnikova, M. J. Berna, N. Gordiyenko, K. Schmid, S. W. Cousins, D. J. S. Thompson, and K. G. Csaky Late Outgrowth Endothelial Progenitor Cells in Patients with Age-Related Macular Degeneration Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2696 - 2708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yodoi, M. Sasahara, T. Kameda, N. Yoshimura, and A. Otani Circulating Hematopoietic Stem Cells in Patients with Neovascular Age-Related Macular Degeneration Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5464 - 5472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lima e Silva, J. Shen, S. F. Hackett, S. Kachi, H. Akiyama, K. Kiuchi, K. Yokoi, M. C. Hatara, T. Lauer, S. Aslam, et al. The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization FASEB J, October 1, 2007; 21(12): 3219 - 3230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Campos, J. Amaral, S. P. Becerra, and R. N. Fariss A Novel Imaging Technique for Experimental Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5163 - 5170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I A Bhutto, D S McLeod, C Merges, T Hasegawa, and G A Lutty Localisation of SDF-1 and its receptor CXCR4 in retina and choroid of aged human eyes and in eyes with age related macular degeneration Br. J. Ophthalmol., July 1, 2006; 90(7): 906 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Sheridan, D. Rice, P. S. Hiscott, D. Wong, and D. L. Kent The Presence of AC133-Positive Cells Suggests a Possible Role of Endothelial Progenitor Cells in the Formation of Choroidal Neovascularization. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1642 - 1645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Chan-Ling, L. Baxter, A. Afzal, N. Sengupta, S. Caballero, E. Rosinova, and M. B. Grant Hematopoietic Stem Cells Provide Repair Functions after Laser-Induced Bruch's Membrane Rupture Model of Choroidal Neovascularization Am. J. Pathol., March 1, 2006; 168(3): 1031 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yokota, Y. Kawakami, Y. Nagai, J.-x. Ma, J.-Y. Tsai, P. W. Kincade, and S. Sato Bone Marrow Lacks a Transplantable Progenitor for Smooth Muscle Type {alpha}-Actin-Expressing Cells Stem Cells, January 1, 2006; 24(1): 13 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Howson, A. C. Aplin, M. Gelati, G. Alessandri, E. A. Parati, and R. F. Nicosia The postnatal rat aorta contains pericyte progenitor cells that form spheroidal colonies in suspension culture Am J Physiol Cell Physiol, December 1, 2005; 289(6): C1396 - C1407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. O'Neill IV, B. R. Wamhoff, G. K. Owens, and T. C. Skalak Mobilization of Bone Marrow-Derived Cells Enhances the Angiogenic Response to Hypoxia Without Transdifferentiation Into Endothelial Cells Circ. Res., November 11, 2005; 97(10): 1027 - 1035. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Paintlia, M. K. Paintlia, M. Khan, T. Vollmer, A. K. Singh, and I. Singh HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis FASEB J, September 1, 2005; 19(11): 1407 - 1421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nakamura, F. Ishikawa, K.-h. Sonoda, T. Hisatomi, H. Qiao, J. Yamada, M. Fukata, T. Ishibashi, M. Harada, and S. Kinoshita Characterization and Distribution of Bone Marrow-Derived Cells in Mouse Cornea Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 497 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sengupta, S. Caballero, R. N. Mames, A. M. Timmers, D. Saban, and M. B. Grant Preventing Stem Cell Incorporation into Choroidal Neovascularization by Targeting Homing and Attachment Factors Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 343 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Apte, R. A. Barreiro, E. Duh, O. Volpert, and T. A. Ferguson Stimulation of Neovascularization by the Anti-angiogenic Factor PEDF Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4491 - 4497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Ohlmann, E. Adamek, A. Ohlmann, and E. Lutjen-Drecoll Norrie Gene Product Is Necessary for Regression of Hyaloid Vessels Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2384 - 2390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. Cousins, D. G. Espinosa-Heidmann, and K. G. Csaky Monocyte Activation in Patients With Age-Related Macular Degeneration: A Biomarker of Risk for Choroidal Neovascularization? Arch Ophthalmol, July 1, 2004; 122(7): 1013 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. I. Dorrell, A. Otani, E. Aguilar, S. K. Moreno, and M. Friedlander Adult bone marrow-derived stem cells use R-cadherin to target sites of neovascularization in the developing retina Blood, May 1, 2004; 103(9): 3420 - 3427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. J. Suner, D. G. Espinosa-Heidmann, M. E. Marin-Castano, E. P. Hernandez, S. Pereira-Simon, and S. W. Cousins Nicotine Increases Size and Severity of Experimental Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 311 - 317. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
